Male hypogonadism and skeletal health

Cauley, 2010, Osteoporotic Fractures in Men Study (MrOS) Research GroupSex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density - the osteoporotic fractures in men study., J Clin Endocrinol Metab, 95, 4314, 10.1210/jc.2009-2635

Watts, 2012, Endocrine SocietyOsteoporosis in men: an Endocrine Society clinical practice guideline., J Clin Endocrinol Metab, 97, 1802, 10.1210/jc.2011-3045

Walsh, 2012, Cortical consolidation of the radius and tibia in young men and women., J Clin Endocrinol Metab, 97, 3342, 10.1210/jc.2012-1677

Boonen, 2011, EMAS GroupInfluence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European Male Ageing Study (EMAS)., Eur J Endocrinol, 165, 977, 10.1530/EJE-11-0353

Pepene, 2011, Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism., Clin Invest Med, 34, E232, 10.25011/cim.v34i4.15365

Tajar, 2012, EMAS GroupCharacteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)., J Clin Endocrinol Metab, 97, 1508, 10.1210/jc.2011-2513

Ward, 2011, EMAS study groupInfluence of age and sex steroids on bone density and geometry in middle-aged and elderly European men., Osteoporos Int, 22, 1513, 10.1007/s00198-010-1437-5

Ackerman, 2012, Estradiol levels predict bone mineral density in male collegiate athletes: a pilot study., Clin Endocrinol (Oxf), 76, 339, 10.1111/j.1365-2265.2011.04212.x

Guadalupe-Grau, 2010, Bone mass and the CAG and GGN androgen receptor polymorphisms in young men., PLoS One, 5, e11529, 10.1371/journal.pone.0011529

Drake, 2012, Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis., J Clin Endocrinol Metab, 97, 1861, 10.1210/jc.2011-3058

Fink, 2006, Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men., J Clin Endocrinol Metab, 91, 3908, 10.1210/jc.2006-0173

Woo, 2012, Sex steroids and bone health in older Chinese men., Osteoporos Int, 23, 1553, 10.1007/s00198-011-1552-y

Amin, 2006, Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study., Am J Med, 119, 426, 10.1016/j.amjmed.2005.10.048

Trimpou, 2012, Secular trends in sex hormones and fractures in men and women., Eur J Endocrinol, 166, 887, 10.1530/EJE-11-0808

Ferlin, 2011, Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism., J Clin Endocrinol Metab, 96, E739, 10.1210/jc.2010-1878

Bojesen, 2011, Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone., Osteoporos Int, 22, 1441, 10.1007/s00198-010-1354-7

Saylor, 2011, Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer., J Urol, 186, 482, 10.1016/j.juro.2011.03.111

Hamilton, 2010, Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy., J Clin Endocrinol Metab, 95, E456, 10.1210/jc.2010-0902

Wadhwa, 2011, Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer., BJU Int, 107, 1923, 10.1111/j.1464-410X.2010.09726.x

Smith, 2012, Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial., Lancet, 379, 39, 10.1016/S0140-6736(11)61226-9

Kenny, 2010, Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty., J Am Geriatr Soc, 58, 1134, 10.1111/j.1532-5415.2010.02865.x

Boonen, 2012, Fracture risk and zoledronic acid therapy in men with osteoporosis., N Engl J Med, 367, 1714, 10.1056/NEJMoa1204061

Orwoll, 2012, A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density., J Clin Endocrinol Metab, 97, 3161, 10.1210/jc.2012-1569